Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity (Q43275812)
Jump to navigation
Jump to search
scientific article published on 25 August 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity |
scientific article published on 25 August 2009 |
Statements
1 reference
Engineered anti-CD20 antibodies with enhanced complement-activating capacity mediate potent anti-lymphoma activity (English)
1 reference
Akito Natsume
1 reference
Yukiko Shimizu-Yokoyama
1 reference
Mitsuo Satoh
1 reference
Kenya Shitara
1 reference
Rinpei Niwa
1 reference
25 August 2009
1 reference
1 reference
100
1 reference
12
1 reference
2411-2418
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference